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Background: Basic Helix Loop Helix (bHLH) proneural transcription factors are master regulators of neurogenesis that
act at multiple stages in this process. We have previously demonstrated that multi-site phosphorylation of two
members of the proneural protein family, Ngn2 and Ascl1, limits their ability to drive neuronal differentiation when
cyclin-dependent kinase levels are high, as would be found in rapidly cycling cells. Here we investigate potential
phospho-regulation of proneural protein NeuroD4 (also known as Xath3), the Xenopus homologue of Math3/NeuroM,
that functions downstream of Ngn2 in the neurogenic cascade.
Results: Using the developing Xenopus embryo system, we show that NeuroD4 is expressed and phosphorylated
during primary neurogenesis, and this phosphorylation limits its ability to drive neuronal differentiation.
Phosphorylation of up to six serine/threonine-proline sites contributes additively to regulation of NeuroD4 proneural
activity without altering neuronal subtype specification, and number rather than location of available phospho-sites is
the key for limiting NeuroD4 activity. Mechanistically, a phospho-mutant NeuroD4 displays increased protein stability
and enhanced chromatin binding relative to wild-type NeuroD4, resulting in transcriptional up-regulation of a range of
target genes that further promote neuronal differentiation.
Conclusions: Multi-site phosphorylation on serine/threonine-proline pairs is a widely conserved mechanism of limiting
proneural protein activity, where it is the number of phosphorylated sites, rather than their location that determines
protein activity. Hence, multi-site phosphorylation is very well suited to allow co-ordination of proneural protein activity
with the cellular proline-directed kinase environment.
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Basic helix-loop-helix (bHLH) transcription factors are
master regulators during development, acting in all three
embryonic germ layers and establishing a complex net-
work of interactions that direct cell fate towards speci-
fied lineages [1–4]. Within this family, proneural bHLH
proteins such as Neurogenin2 (Ngn2) and Ascl1 have
well-established roles as neuronal determination and dif-
ferentiation factors [1, 5]; this function is highly con-
served from invertebrate Drosophila [6] and through* Correspondence: ap113@cam.ac.uk
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unless otherwise stated.vertebrate models such as zebrafish and Xenopus [7],
chick [8], rodent and humans [9]. A dynamic interplay
exists whereby these proneural bHLH proteins on one
hand cell autonomously drive differentiation, yet also
non-cell autonomously promote progenitor maintenance
through Notch signalling and the actions of inhibitory
neurogenic bHLH proteins of the Hes family [10]. More-
over, their role in co-ordinating cell cycle and differenti-
ation is also becoming apparent [11–13].
Proneural protein activity may lie at the heart of
mechanisms that allow cell cycle exit to be co-ordinated
with differentiation. For instance, we have previously dem-
onstrated that both Ngn2 and Ascl1 undergo multi-siten Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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reduces their ability to drive neuronal differentiation under
conditions of high cyclin dependent kinase (cdk) activity
[14–16]. Accordingly, phospho-mutant versions of Ngn2
and Ascl1 show enhanced proneural activity in both Xen-
opus embryos and mammalian cell models [14, 16]. This
raises important questions: Firstly, is this mechanism of
phospho-regulation conserved more widely amongst
proneural bHLH transcription factors? Secondly, if
phospho-regulation can influence generic proneural
activity, does it also influence the subtype specification
of neuronal progeny?
Here, we investigate phospho-regulation of the pro-
neural protein NeuroD4 [17], the Xenopus protein also
known as Xath3, and homologue of mammalian Math3/
NeuroM. Focussing on Xenopus primary neurogenesis,
we show that NeuroD4 is expressed and phosphorylated
at neural plate stages in the developing embryo, and this
limits its ability to drive primary neurogenesis. Phos-
phorylation of up to six sites additively contributes to
regulation of NeuroD4 proneural activity, without alter-
ing neuronal subtype specification. Mechanistically, we
demonstrate that phospho-mutant NeuroD4 has both
enhanced protein stability relative to wild-type NeuroD4
in vivo, and also increased chromatin binding at neural
plate stages. Our findings indicate that cell-cycle medi-
ated multi-site phosphorylation is a widely conserved
mechanism of regulating proneural protein activity.Results
NeuroD4 contains conserved proline-directed
phosphorylation sites
bHLH proteins are subdivided into families on the
basis of sequence conservation, and NeuroD4 is
grouped in the Atonal family, related to the Drosophila
proneural gene atonal [18]. Species homologues of
each proneural protein often show a high degree of se-
quence conservation in the bHLH domain that medi-
ates DNA-binding and protein dimerisation, but N and
C terminal domains can be significantly divergent in
sequence [1]. hese regions are suggested to be unstruc-
tured domains and present prime sites for post transla-
tional modifications such as phosphorylation [19].
Protein sequence alignment for human (genbank acces-
sion number NP 067014.2), mouse (genbank accession
number NP 031527.1) and Xenopus (genbank accession
number NP 001081213.1) NeuroD4 homologues show
not only the strong sequence conservation in the bHLH
domain, but also sequence conservation in potential
proline-directed kinase sites (serine or threonine followed
by a proline, Fig. 1a) that conform to the basic consensus
sites for phosphorylation by cyclin dependent kinases
(cdks) [20]. In NeuroD4 there are four serine-proline (SP)sites and two threonine-proline (TP) sites; five out of six
of these sites are highly conserved with the mouse and hu-
man proteins, while the mouse and human proteins have
additional non-conserved TP sites in the C terminus that
are not shared with the Xenopus protein (Fig. 1a).
Limited evidence for phospho-regulation of NeuroD4
has been previously described; a phospho-mimetic version
of NeuroD4 with aspartic acid replacing serine-89 within
the basic domain impairs the expression of anterior neural
markers without affecting the level of induced neurogen-
esis relative to wild-type (WT) NeuroD4 [17]. We set out
to investigate a potential regulatory role of the SP/TP sites
in NeuroD4 by exploring primary neurogenesis in the de-
veloping Xenopus embryo as a model system.
NeuroD4 is expressed in the neural plate and
phosphorylated during primary neurogenesis
The murine homologue Math3 is expressed in the devel-
oping spinal cord from embryonic day (E) 8.5 and then
later in the developing brain and retina [17]. Similarly,
expression of chick homologue NeuroM in spinal cord
and optic tectum coincides with cells in a transition
stage between proliferation in the ventricular zone (VZ)
and differentiation and migration of post-mitotic neu-
rons [21]. Consistent with playing a similar role in Xen-
opus, NeuroD4 expression is first detected from stage 12
in the presumptive neural plate [17], becoming localised
at stage 14 to the trigeminal ganglia and three bilateral
stripes of differentiating primary neurons (Fig. 1b); these
give rise to somato-sensory (Rohon-Beard neurons), in-
terneurons, and somato-motor neurons respectively
[22]. NeuroD4 expression persists at a high level in the
brain and retina [17]. Firstly, we investigated whether
NeuroD4 is phosphorylated during primary neurogenesis
in developing Xenopus embryos. Extracts were prepared
from stage 13 embryos injected with an HA-tagged wild
type (WT) NeuroD4 mRNA, and western blot analysis
shows the presence of a broad band of NeuroD4 protein
(Fig. 1c). Protein migration is significantly enhanced by
treatment with a broad-spectrum phosphatase, demon-
strating that NeuroD4 is phosphorylated on at least one
site. We next investigated the effect of mutating poten-
tial SP and TP phosphorylation sites on NeuroD4 neuro-
genic function.
A phospho-mutant NeuroD4 promotes enhanced
neuronal differentiation in vivo
To determine the activity of NeuroD4 when phosphoryl-
ation on SP and TP sites is prevented, we generated a
phospho-mutant version where all six SP/TP sites are
mutated to alanine-proline (AP), creating 6T/S-A Neu-
roD4 (Fig. 2a). In order to compare their proneural
activity, mRNA encoding WT and 6T/S-A NeuroD4
proteins were injected unilaterally into two-cell stage
AB C
Fig. 1 NeuroD4 is expressed and phosphorylated during primary neurogenesis (A-C). a Protein sequence alignment for human, mouse and
Xenopus NeuroD4 homologues using Clustal W. The conserved bHLH domain is indicated in green and SP/TP sites are highlighted in red. A
consensus line is also shown below the alignment to indicate the degree of conservation of amino acids at each position: (*) denotes identical
residues in all three sequences; (:) denotes highly conserved residues; (.) denotes weakly conserved residues. b Endogenous expression of
NeuroD4 at stage 14 (i) and neural-β-tubulin at stage 17 (ii) was determined by whole mount ISH (white arrows correspond to zones of primary
neurogenesis; TG = trigeminal ganglia). Dorso-ventral views, anterior up, stages as indicated. c Western Blot analysis of extracts from stage 13
embryos injected with an HA-tagged wild type (WT) NeuroD4 mRNA, either with or without protein phosphatase treatment. Tubulin was used as
a loading control
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assayed at stage 18 (Fig. 2b-d). Consistent with previous
reports [17, 23], over-expression of WT NeuroD4 pro-
duces a mild to moderate increase in neural-β-tubulin
expression, seen in both the neural plate and lateral
ectoderm of embryos. 6T/S-A NeuroD4 induces signifi-
cantly greater ectopic neural-β-tubulin expression than
that induced by WT NeuroD4, as judged by in situ hy-
bridisation (ISH) and by qRT-PCR. Hence, preventing
modification of SP/TP sites substantially enhances the
proneural activity of NeuroD4, similar to our previousfindings with Ngn2 and Ascl1 [14–16]. Phosphorylation
on multiple SP and TP sites may therefore be a widely
conserved mechanism for limiting the activity of bHLH
proneural proteins.
Enhanced target gene expression by phospho-mutant
NeuroD4
Preventing multi-site phosphorylation of Ngn2 and Ascl1
enhances the transcriptional activation of a number of
downstream targets. However, not all targets show a simi-
lar level of up-regulation by the phospho-mutant proteins
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Fig. 2 (See legend on next page.)
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Fig. 2 Phospho-mutant 6T/S-A NeuroD4 has increased proneural activity relative to WT NeuroD4 (a-g). a Schematic representation of WT NeuroD4
and full phospho-mutant 6T/S-A NeuroD4 protein sequences, indicating the relative positions of the six SP or TP sites that have been mutated to AP
sites. b-g Two-cell stage embryos were unilaterally injected with 100 pg of either WT or 6T/S-A NeuroD4 mRNA, and at stage 18, gene expression was
assayed by qRT-PCR (b), or by whole mount ISH (d-g) with representative embryo images shown in (c). For qRT-PCR analysis (b) significance is
calculated as described in the methods section for phospho-mutant NeuroD4 relative to WT NeuroD4 (blue adjoining lines and stars) and relative to
uninjected control embryos (shown with black stars) [n = 5]; (p < 0.05) = *; (p < 0.025) = **; (p < 0.0125) = ***. For ISH analysis, embryos were scored
according to the scale described in Additional file 1 for expression of neural-β-tubulin (D [n = 100–115]), p27Xic1 (E [n = 24-33]), xMyt1 (F [n = 26-32]),
and xNeuroD1 (G [n = 23-28]). Views in (C [i-iii]) are dorso-ventral (DV); views in (C [iv]) are rostro-caudal (RC) with dorsal surface facing up, trigeminal
ganglia indicated by arrows. All images show injected side to the right
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stance xDelta, which is known to have an epigenetically
“available” promoter shows similar up-regulation by WT
and S-A mutant versions of Ngn2, while xNeuroD1 that
requires more chromatin modification for activation shows
substantially greater activation by the phospho-mutant
compared to the wild-type protein [15, 24]. Hence epigen-
etic availability of target genes appears to contribute to the
sensitivity of targets to Ngn2 phosphorylation. To investi-
gate whether distinct downstream targets of NeuroD4
respond differently to NeuroD4 phospho-status, we
investigated expression of xDelta [25] and xNeuroD1
[26] as markers of progenitor maintenance and neur-
onal differentiation respectively, along with other po-
tential targets of NeuroD4 that can promote neuronal
differentiation, namely xMyt1 [27] and p27Xic1 [28]
(Fig. 2b-g).
WT NeuroD4 over-expression results in a four-fold in-
crease in both xMyt1 and xNeuroD1 expression, but
does not significantly up-regulate p27Xic1 or xDelta at
this level of overexpressed mRNA. In contrast, 6T/S-A
NeuroD4 up-regulates all four transcripts relative to
both uninjected controls and WT NeuroD4 (Fig. 2b). Of
note is the five-fold increase in xDelta expression by 6T/
S-A NeuroD4 compared a negligible increase by WT
NeuroD4; WT and 9S-A Ngn2 give similar up-regulation
of xDelta [15], indicating differences in promoter activa-
tion by these two proneural proteins. In addition, 9S-A
Ngn2 induces a fifty-fold increase in xNeuroD1 [15],
while 6T/S-A NeuroD4 induces a much more modest
nine-fold increase that appears largely localised to the
trigeminal ganglia (Fig. 2c). This indicates that NeuroD4
may have additional requirements for regionally re-
stricted co-factors to drive neuronal differentiation not
needed by Ngn2. Thus, while xDelta and xNeuroD1 are
downstream target for both Ngn2 and NeuroD4 [23],
the dynamics of downstream promoter activation and
their sensitivity to proneural protein phospho-status
clearly differ between the two proneural proteins.
We have previously demonstrated that the cdk inhibitor
(cdki) p27Xic1 is required for primary neurogenesis, play-
ing a dual role in slowing the cell cycle and independently
promoting differentiation by stabilisation of the Ngn2
protein [28]. However, perhaps surprisingly, p27Xic1expression has not been shown to be up-regulated by
overexpressed Ngn2 [29]. As NeuroD4 is expressed at the
point of cell cycle exit, we explored whether NeuroD4
could transcriptionally activate p27Xic1, facilitating the
transition from progenitor to differentiating neuron. WT
NeuroD4 is unable to induce p27Xic1 expression, but 6T/
S-A NeuroD4 induces a 2.5 fold increase in p27Xic1 mes-
sage by qRT-PCR (Fig. 2b). Interestingly, in situ hybridisa-
tion reveals that p27Xic1 is induced by 6T/S-A NeuroD4
in the lateral ectoderm of the embryo but is also sup-
pressed in the underlying myotome (Fig. 2c). This may
potentially result in an underestimation of p27Xic1 induc-
tion by 6T/S-A NeuroD4 in the neural plate and ectoderm
as measured by qRT-PCR, which nevertheless shows more
than a 2-fold increase compared to uninjected embryos.
In summary, a phospho-mutant form of NeuroD4 dis-
plays substantially enhanced ability to drive neuronal dif-
ferentiation in Xenopus, and in contrast to phospho-
mutant Ngn2 [15], shows an enhanced expression of all
the potential downstream targets tested, as compared to
wild-type NeuroD4.
NeuroD4 activity is limited by the number rather than the
location of available phospho-sites
In some bHLH proteins where phosphorylation of SP
and/or TP sites has been shown to regulate protein ac-
tivity, individual phosphorylation sites have particularly
important regulatory significance, for example S200 in
MyoD [30] or S147 in Olig2 [31]. In contrast, our earlier
work indicates that it is the number of available
phospho-sites in Ngn2, rather than their precise loca-
tion, that controls Ngn2 differentiation activity [14, 15].
To investigate whether particular SP/TP sites have spe-
cific regulatory roles or whether it is the number of sites
rather than their location that determines NeuroD4 ac-
tivity, we generated a series of mutant versions of Neu-
roD4, starting with a panel in which individual SPs or
TPs were mutated to AP (Fig. 3a), and tested their abil-
ity to promote ectopic neurogenesis after mRNA
injection.
Mutation of individual SP sites generates mutants with
activity similar to WT NeuroD4, while mutation of indi-
vidual TP sites results in a small increase in activity
(Fig. 3b-d). However, this increase is modest compared
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Fig. 3 Similar levels of proneural activity are seen amongst single site mutants (a-d). a Schematic representation of the single site phospho-mutant
NeuroD4 constructs demonstrating the relative position of the SP or TP site mutated to AP in each. Two-cell stage embryos were unilaterally injected
with 100 pg mRNA of the respective NeuroD4 construct and assayed at stage 18 for expression of neural-β-tubulin by qRT-PCR (B[n = 3]), or whole
embryo ISH (C[n = 51-77]) with representative images shown in (d). Views are dorso-ventral with injected side to the right; (p < 0.05) = *; (p < 0.025) = **;
(p < 0.0125) = ***
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demonstrating that multiple SP/TP sites must be mutated
to achieve maximal activity. SP and TP sites in NeuroD4
are found in pairs, and two of these pairs are found in
highly conserved regions. It is possible that, when one of
these sites is mutated, phosphorylation switches to its
neighbour, but nevertheless phosphorylation at the location
of these paired sites could be important for controlling
NeuroD4 activity. Alternatively, the location of phosphoryl-
ation could be less important for regulation than the num-
ber of sites available.
To distinguish between these alternative possibilities, a
second panel of phospho-mutant constructs were made in
which pairs of adjacent SP or TP sites were mutated to-
gether (Fig. 4a) and assayed in Xenopus embryos as
described above. All three paired mutants produce a simi-
lar six to seven fold increase in neural-β-tubulin expres-
sion that is significantly higher than that induced by WT
NeuroD4, but still substantially lower than that induced
by the full phospho-mutant 6T/S-A NeuroD4 (Fig. 4b-e).
Therefore, mutation of paired residues enhances NeuroD4
proneural activity compared to single site mutations, but
the location of these paired sites does not influence the
level of NeuroD4 activity; collective mutation of all six
sites is required for the full neurogenic activity.
Our data is therefore consistent with a model in which
proneural activity varies with the number rather than loca-
tion of sites phosphorylated. However, the data presented
above do not distinguish between either a linear model,
whereby mutation of each additional phosphorylation site
additively increases the neurogenic activity of NeuroD4, or
a threshold model, whereby mutation of a particular num-
ber of sites is enough to trigger a dramatic increase in ac-
tivity. In order to investigate these two possibilities, a
further panel of cumulative mutants were made, where
each mutant SP/TP site was additively mutated from the N
terminus to generate 1S-A, 2S-A, 3T/S-A etc. (Fig. 5a).
Both qRT-PCR analysis and semi-quantitative analysis of
ectopic neurogenesis as judged by in situ hybridisation
show that sequential introduction of additional mutations
creates a step-wise increase in neural-β-tubulin expression
(Fig. 5b-d). Taken together, our data support the linear
model where it is the number not the location of SP/TP
sites that controls the activity of NeuroD4. Under this
model, NeuroD4 may act as a “rheostat” to sense the level
of proline-directed kinase activity and translate this into
propensity to drive neuronal differentiation.Phosphorylation of NeuroD4 does not influence neuronal
subtype specification
One way in which bHLH proteins can have context-
dependent roles in addition to their generic proneural func-
tions is through participation in transcription factor com-
plexes with spatially or temporally restricted cofactors. An
excellent example of this is during neuronal subtype deter-
mination, where proneural proteins form complexes with
homeodomain proteins to direct subtype identity, as occurs
in the spinal cord [32] or retina [33]. In some cases, this has
been shown to be influenced by specific phosphorylation
events [34], and in the Xenopus retina, subtype specification
is temporally regulated by post-translational modification of
bHLH factors such as NeuroD1 [35]. Mammalian Math3
has known roles in retinal subtype specification in cooper-
ation and cross-regulation with other proneural proteins
[36], and over-expression of WT NeuroD4 in the developing
Xenopus retina promotes the formation of both ganglion
and photoreceptor cells [23]. We therefore investigated
whether phospho-regulation may also influence subtype
specification by NeuroD4, in addition to regulating its gen-
eric proneural activity.
The bilateral stripes of Xenopus primary neurons give
rise to sensory neurons, interneurons and motor neu-
rons (lateral to medial), which can be distinguished by
expression of xHox11L2 [37], xVsx1 [38], and xHb9 re-
spectively [39]. All three of these marker genes are en-
dogenously expressed at stage 18, enabling their relative
expression to be determined alongside neural-β-tubulin
(Fig. 6). Initial analysis of expression of subtype markers
was conducted by qRT-PCR, following over-expression
of WT or 6T/S-A NeuroD4 mRNA (Fig. 6a-b). The rela-
tive increase in neural-β-tubulin expression (four fold
for WT and 20 fold for 6T/S-A NeuroD4) is paralleled
by the increase in sensory neuron marker xHox11L2
(five-fold for WT and 17 fold for 6T/S-A NeuroD4). In
contrast, no significant differences are seen in motor
neuron marker xHb9, and in both WT and 6T/S-A Neu-
roD4 injected embryos there is a reduction in interneuron
marker xVsx1. Perron and colleagues also observed a reduc-
tion of interneuron marker Pax2 following over-expression
of WT NeuroD4 in non-neural ectoderm [23], so this may
suggest that interneuron cell fate is being diverted towards
sensory cell fate and additionally, NeuroD4-induced ectopic
neurons are adopting a sensory identity. We confirmed that
6T/S-A NeuroD4 induces sensory neurons like WT Neu-
roD4 by in situ hybridisation (Fig. 6c). Ectopic neurons
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Fig. 4 Similar levels of proneural activity are seen amongst paired site mutants (a-d). a Schematic representation of the paired site phospho-mutant
NeuroD4 constructs. Two-cell stage embryos were unilaterally injected with 100 pg mRNA of the respective NeuroD4 construct and assayed at stage
18 for expression of neural-β-tubulin by qRT-PCR (B[n = 3]), or whole embryo ISH (C[n = 62-79]) with representative images shown in (d). Views are
dorso-ventral with injected side to the right; (p < 0.05) = *; (p < 0.025) = **; (p < 0.0125) = ***
Hardwick and Philpott Neural Development  (2015) 10:15 Page 9 of 18induced by over-expression of WT xNgn2 and WT Neu-
roD4 have previously been described as Rohon-Beard sen-
sory neurons [23, 40] and in another vertebrate model,
chick homologue NeuroM is expressed in the region of the
developing sensory neurons in the dorsal root ganglia [21].
This may therefore be the default path of neuronal identity
induced by this Neurogenin2-NeuroD4 transcription factor
cascade, and SP/TP phosphorylation does not obviously in-
fluence neuronal subtype identity. The lack of other neur-
onal subtypes may be due to a lack of necessary cofactors or
extrinsic signals that are required for alternative cell fates.
Taken together, these results indicate that phospho-mutant
NeuroD4 has considerably enhanced neurogenic activity but
phospho-status has no significant effect on the subtype of
neurons generated.
NeuroD4 phospho-status affects both protein
accumulation and chromatin binding
We have so far demonstrated that NeuroD4 is expressed
and phosphorylated during primary neurogenesis in
Xenopus embryos, and mutation of phosphorylation
sites additively enhances the ability of NeuroD4 to
drive neuronal differentiation. We then investigated
the mechanisms by which 6T/S-A NeuroD4 may exert
its increased neurogenic activity. We show above
(Fig. 2) that phospho-mutant 6T/S-A NeuroD4 gives
enhanced transcriptional activation of several down-
stream target genes. Two possibilities that may ac-
count for this are that phospho-mutant NeuroD4
accumulates to higher levels than the wild-type protein
and/or it has a greater ability to associate with DNA.
To test these, we looked at protein levels in neural
plate embryos and investigated association of NeuroD4
with embryonic chromatin at this stage.
In order to compare protein levels in vivo, HA-tagged
WT or 6T/S-A NeuroD4 mRNA was injected into one
cell embryos and extracts were prepared from stage 13
embryos for western blot analysis (Fig. 7a-b). WT NeuroD4
protein migrates as a broad band whereas 6T/S-A
NeuroD4 migrates as a single band, demonstrating that
these six SP/TP sites that are mutated in the phospho-
mutant account for the phosphorylation seen in the
WT protein (as discussed for Fig. 1c). The density of
the NeuroD4 protein bands were calculated relative to
the respective tubulin loading control: Injection of the
same amount of WT or 6T/S-A NeuroD4 mRNA re-
sults in a 1.5 fold increase in 6T/S-A NeuroD4 band
compared to WT NeuroD4.We then investigated whether we also see enhanced 6T/
S-A NeuroD4 associated with embryonic chromatin. After
injection of equal amounts of mRNA, cross-linking was
performed in stage 14 embryos and nuclei were extracted
for western blot analysis. A cytoplasmic fraction was also
collected and relative protein levels of WT and 6T/S-A
NeuroD4 were quantified relative to tubulin loading con-
trol for the cytoplasmic fraction, and relative to Histone
H3 for the chromatin fraction (Fig. 7c, d). No tubulin pro-
tein is detected in the chromatin fraction, confirming
successful chromatin isolation. For the cytoplasmic frac-
tion, we find an approximately two-fold higher protein
level of phospho-mutant NeuroD4 relative to WT protein,
similar to that seen in the whole embryo extracts. How-
ever, for chromatin-associated protein, we find 3.5 fold
more phospho-mutant NeuroD4 compared to WT Neu-
roD4, demonstrating an increased DNA binding affinity.
Thus, the enhanced ability of phospho-mutant NeuroD4
to drive neuronal differentiation relative to WT NeuroD4
appears to reflect a combination of a greater level of 6T/
S-A NeuroD4 protein and a greater affinity for DNA com-
pared to the WT protein.
Discussion
Multi-site phosphorylation is a conserved regulatory
mechanism amongst proneural proteins
A sizeable number of proneural bHLH transcription fac-
tors have been identified that act at different stages in
the specification, differentiation and maturation of a
neuron [1], but how their different roles are controlled
and co-ordinated is still poorly understood. We have
previously shown that two bHLH proteins are controlled
by multi-site phosphorylation on serine-proline sites;
Ascl1, which regulates autonomic neuron formation in
Xenopus [41] and generally a GABAergic phenotype
(among other roles) [42], and Neurogenin2, an inducer
of primary neuron formation in the developing Xenopus
embryo [43] and generally of glutamatergic neurons
[42]. Multi-site phosphorylation by cdks regulates the
ability of Ascl1 and Ngn2 to control the proliferation
versus differentiation decision; when cells are rapidly
cycling, high cdk levels suppress the ability of these pro-
neural proteins to drive differentiation [14–16].
NeuroD4 (otherwise known as Math3 and NeuroM)
acts downstream of Ngn2 in primary neurogenesis [23]
and its expression timing and pattern is consistent
with a role in co-ordinating and/or driving the transition
between proliferation and differentiation after that
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Fig. 5 Cumulative mutation of phosphorylation sites creates step-wise increases in proneural activity (a-d). a Schematic representation of the
phospho-mutant series of constructs demonstrating the SP and/or TP sites that are mutated to AP sites in each. The series consists of cumulative
mutation of sites, working from N to C termini. Two-cell stage embryos were unilaterally injected with 100 pg mRNA of the respective NeuroD4
construct and assayed at stage 18 for expression of neural-β-tubulin by qRT-PCR (B[n = 3]), or whole embryo ISH (C[n = 59-77]) with representative
images shown in (d). Views are dorso-ventral with injected side to the right; (p < 0.05) = *; (p < 0.025) = **; (p < 0.0125) = ***
Hardwick and Philpott Neural Development  (2015) 10:15 Page 11 of 18differentiation decision has been made. We show here
that the ability of NeuroD4 to drive neuronal differenti-
ation is also limited by multi-site phosphorylation. Thus,
despite playing roles at differing stages of neuronal specifi-
cation and differentiation, a similar role for multi-site
phospho-regulation is conserved amongst bHLH proneural
proteins, even though the precise kinase environment eachA
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differences in scale [n= 3]. Whole embryo ISH was also conducted to compare
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While proneural proteins can be phosphorylated by cdk1
and cdk2-dependent kinases [14, 16], other proline-
directed kinases include GSK3beta, MAP kinases, cdk5
and the cdks more commonly associated with transcription
including cdk7 and cdk8, may also potentially target these
proteins throughout the differentiation process.B
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Fig. 7 6T/S-A NeuroD4 shows enhanced protein stability and enhanced chromatin binding relative to WT NeuroD4 (a-d). Embryos were injected
at the one cell stage with 200 pg mRNA encoding HA-tagged versions of either WT or 6T/S-A NeuroD4. a Western blot analysis on extracts
prepared from stage 13 embryos, with tubulin as a loading control. b The density of the protein band for WT or 6T/S-A NeuroD4 was quantified
and expressed relative to the tubulin loading control of each sample. Mean values are shown from independent duplicate samples with the
standard error of the mean. c At stage 14, cross-linking and chromatin isolation were performed prior to western blot analysis as before. No
HA-tagged NeuroD4 protein was detected in the uninjected embryos confirming antibody specificity, and no tubulin protein was detected in the
chromatin fraction. d NeuroD4 protein bands were again quantified relative to tubulin or histone H3 bands for cytoplasmic and chromatin
fractions respectively. Mean values are shown from independent duplicate samples with the standard error of the mean
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mechanism to regulate proneural activity
Previous work investigating multi-site phospho-regulation
of Ascl1 and Ngn2 indicates that the number of sites avail-
able for phosphorylation is a more important determinant
of proneural protein activity than the exact location of
those sites [14, 16]. We see a similar phenomenon with
NeuroD4. The ability to inhibit NeuroD4-driven neuro-
genesis does not reside with a single SP or TP site, as no
single mutant shows activity close to the full phospho-
mutant; the only single residues that, when mutated, can
significantly enhance NeuroD4 activity are T237 and
T245. A single TP site was noted previously in Ngn2 but
was not identified as playing an important regulatory role
[14, 15] (and data not shown), and Xenopus Ascl1 has no
TP sites, so NeuroD4 is the first example of TPs playing a
role in proline-directed multi-site phospho-regulation of
proneural protein activity.
SP and TP sites in NeuroD4 are clustered into three
pairs of sites, two pairs of which are found within
stretches of highly conserved residues. To see if SP/TP
sites in these pairs are redundant to each other, we
tested mutants where both members of each pair were
mutated simultaneously. While NeuroD4 with the mutated
pairs of sites show more activity than the wild-type protein
or single SP/TP site mutants, each of the paired mutants
results in similar enhancement of activity (approximately1.5 to 2-fold compared to WT NeuroD4) and none show
activity approaching the full phospho-mutant. Thus, muta-
tion of single or pairs of SP/TP sites does not result in a
NeuroD4 protein with the high level of activity of the full
phospho-mutant. These findings support the hypothesis
that it is the number of phospho-sites available and not
phosphorylation at a particular location that controls pro-
neural protein activity. To test this hypothesis further, we
generated a phospho-mutant series where SP/TP sites were
cumulatively mutated from the N-terminus towards the C-
terminus of the protein. This cumulative phospho-mutant
series can also be used to test the alternative of a threshold
versus a rheostat model of phospho-regulation. Under a
threshold model, mutation of a specific number of sites
above a threshold would be enough to give full activation
of NeuroD4. Such threshold regulation has been described
for NFAT transcription factors [44]. A rheostat-like model
of phospho-regulation has previously been described to
control DNA binding by the ets-1 transcription factor,
where mutation of additional phosphorylation sites gives
an incremental increase in DNA binding [45]. In fact, using
our NeuroD4 phospho-mutant series, we see a remarkably
linear increase in both ectopic neurogenesis as scored by in
situ hybridisation, and expression of neural-β-tubulin mea-
sured by qRT-PCR, when potential phosphorylation sites
are cumulatively mutated. Taken together, the results we
describe add considerable weight to a rheostat-like model
Hardwick and Philpott Neural Development  (2015) 10:15 Page 13 of 18whereby multi-site phosphorylation on SP and TP sites is
used as a conserved mechanism to regulate the ability of
proneural proteins to effect neuronal differentiation, allow-
ing a graded response to the kinase environment.
Under-phosphorylated proneural proteins promote
neuronal differentiation through multiple mechanisms
How does phosphorylation control NeuroD4 activity?
Direct downstream targets of NeuroD4 have not been
systematically identified. However, xNeuroD1 and xMyT1
are clearly up-regulated by both Ngn2 and NeuroD4 in a
neurogenic cascade [15, 23, 27] (Fig. 2). xNeuroD1 expres-
sion is enhanced approximately four-fold by WT Neu-
roD4, compared to 20-fold by WT Ngn2 (Fig. 2 and [15])
despite the injection of up to five times more NeuroD4
mRNA, demonstrating that the factors are not inter-
changeable. xNeuroD1 expression is enhanced two-fold in
response to phospho-mutant NeuroD4 or Ngn2 compared
to the respective wild-type proteins, and similarly xMyT1
is three-fold more highly activated by 6T/S-A NeuroD4
than WT NeuroD4 (Fig. 2 and [15]), so un(der) phosphor-
ylated Ngn2 and NeuroD4 both promote neuronal
differentiation.
In contrast to Ngn2 targets that drive differentiation
such as xNeuroD1 and xMyT1, we have seen that
phospho-status of Ngn2 has very little effect on xDelta
expression, which promotes cell non-autonomous pro-
genitor maintenance via Notch signalling [15]. We have
previously proposed that de-phosphorylation of Ngn2
results in an increase in xNeuroD1 expression with little
effect on xDelta; this alone will shift the balance towards
neuronal differentiation and away from progenitor main-
tenance. Indeed, overexpression of phospho-mutant Ngn2
leads to near total neurogenic conversion of the lateral
epidermis, which overcomes any localised Notch signal-
ling [14, 15]. In contrast to the almost uniform neurons
formed on overexpression of phospho-mutant Ngn2, it is
striking that ectopic neurogenesis resulting from 6T/S-A
NeuroD4 occurs in distinct clumps of differentiated neu-
rons separated by regions of epidermis (e.g. see Figs. 2, 3, 4,
5 and 6), indicative of active Notch-mediated lateral inhib-
ition. Unlike Ngn2, 6T/S-A NeuroD4 up-regulates xDelta
expression up to 3-fold compared to WT NeuroD4, which
may account for the different patterns of neurogenic in-
duction that we observe. Thus, while they are components
of the same unidirectional cascade, Ngn2 and NeuroD4
show distinct properties in both regulation of neuronal dif-
ferentiation and maintenance of lateral inhibition.
Cdks can phosphorylate proneural proteins on SP/TP
sites [14, 16]. Our model predicts that as the cell cycle
lengthens and cdk activity drops, de-phosphorylation
of proneural proteins increases and drives neuronal
differentiation further [14–16]. But what causes the ini-
tial drop in cdk levels that potentiates this drive todifferentiate? Cdk inhibitors of the Cip/Kip family play
an important role in both inhibiting cdks and also dir-
ectly potentiating neuronal differentiation [28, 46].
While proneural protein expression results in an in-
crease in cdki protein levels in P19 cells [47], these cdkis
are generally not shown to be direct transcriptional tar-
gets of proneural proteins [13, 29]. We see that the sin-
gle cdki that is required for primary neurogenesis in
Xenopus, p27Xic1 [28] is not transcriptionally up-
regulated by WT NeuroD4. However, two-fold up-
regulation of p27Xic1 is seen with 6T/S-A NeuroD4
(Fig. 2). Up-regulation of cdkis by un(der)phosphorylated
proneural proteins offers a feedback mechanism to further
drive neuronal differentiation once it has been initiated;
enhancing the expression of cdkis will both inhibit cdk ac-
tivity and stabilise proneural proteins and so potentiate
neuronal differentiation. However, what brings about an
initial reduction in proline-directed kinase activity, which
results in accumulation of un(der)phosphorylated pro-
neural proteins and so enhanced proneural protein activity,
remains unclear.
We have previously shown than un(der)phosphory-
lated Ngn2 shows enhanced DNA binding compared to
its phosphorylated counterpart [14]. Western blot ana-
lysis from embryos injected with equal amounts of either
WT or 6T/S-A NeuroD4 mRNA reveals 1.5 times more
phospho-mutant NeuroD4 protein compared to WT
protein. Our previous work has shown that phospho-
status of Ngn2 does not affect its intrinsic protein sta-
bility in vitro [19], but 9S-A Ngn2 shows differentially
enhanced stability relative to WT Ngn2 when co-
incubated with E proteins [15]. Our data suggest that
NeuroD4 may show similar preferential stability of the
phospho-mutant form in the endogenous environment
of the embryo where E proteins are abundant [48]. As
well as this moderately enhanced overall abundance,
we found that 3.5 fold more 6T/S-A NeuroD4 was as-
sociated with chromatin in vivo compared to the wild-
type protein. This reinforces our findings in vitro and
in tissue culture cells showing greater association of
phospho-mutant proneural proteins with E box-containing
DNA [14].
Together with our previous work on Ngn2 and Ascl1
phospho-regulation, the results presented above strengthen
and widens our model whereby un(der)phosphorylation of
multiple proneural transcription factors enhances promoter
dwell-time on their downstream target promoters. En-
hanced dwell-time disproportionately promotes activation
of targets that require extensive chromatin modification
for transcription to occur, particularly genes associated
with differentiation such as xNeuroD1 and xMyT1; pro-
neural proteins can associate with chromatin modification
enzymes such as histone acetyltransferases and swi/snf-
family nucleosome remodellers, and underphosphorylated
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get promoters [24, 49]. Conversely, multi-site phosphoryl-
ation of proneural proteins found when proline-directed
kinases such as cdks are high, limits their chromatin bind-
ing and favours progenitor maintenance. Thus, post-
translational modification of proneural proteins active at
sequential stages in primary neurogenesis can be used to
sense the kinase environment and use this to regulate
neuronal differentiation.
Conclusions
Here we show that proneural bHLH protein NeuroD4 is
expressed and phosphorylated during primary neurogen-
esis in Xenopus embryos. Homologues of NeuroD4 in
other species show strong sequence conservation of poten-
tial proline-directed kinase sites (SP/TP). We have used
the Xenopus embryo model to demonstrate that NeuroD4
proneural activity is regulated by phosphorylation on up to
six SP/TP sites. A multiply phospho-mutant version of
NeuroD4 is able to drive significantly enhanced neurogen-
esis compared to the wild-type protein, although the sub-
type of neurons generated is not altered. Extensive
mutational analysis demonstrates that it is the number ra-
ther than location of available phospho-sites that is the
critical factor for regulation of NeuroD4 activity. NeuroD4
dephosphorylation promotes neuronal differentiation
through a combination of increased protein stability, in-
creased chromatin binding, and consequent up-regulation
of a range of target genes that also promote differenti-
ation. Taken together with previous findings about regula-
tion of the proneural proteins Ngn2 and Ascl1, we
propose that a conserved rheostat-like mechanism of
phospho-regulation enables proneural protein activity to
control the balance between progenitor maintenance and
differentiation in response to the cellular kinase
environment.
Methods
Animal care
Xenopus laevis were housed, bred and treated according
to the guidelines approved by the UK Home Office
under the Animal (Scientific Procedures) Act 1986. All
animal work has been carried out under UK Home Of-
fice Licence and has passed an Institutional ethicalTable 1 Primer sequences for site-directed mutagenesis of NeuroD4
Mutation Sense primer 5′ to 3′
Xath_S197A CATACTTATAATTACCAGGCCCCAGGACTACCCAG
Xath_S202A GGCCCCAGGACTACCCGCTCCTCCTTATGGTAAC
Xath_T237A CATACACTTAACTGTACCGCTCCACCATATGAAGGAG
Xath_T245A TCCACCATATGAAGGAGCTCTAGCACCTCCACTCA
Xath_S261A GGTAATTTTTCTTTGAAGCAAGATAGTGCACCCGATATGGATA
Xath_S272A AATCATATGCATTCAGGGCCCCCTATCCAGCTCTTreview committee assessment, undertaken by the Animal
Welfare and Ethical Review Committee (AWERC) at the
University of Cambridge.
Plasmids and constructs
X. laevis wild-type (WT) NeuroD4 in pCS2+ (Genbank ac-
cession number NM 001087744) was a kind gift from Pro-
fessor Shin-Ichi Ohnuna (University College London, UK).
For western blot detection, HA-tagged WT NeuroD4 in
pCS2+ was generated by PCR. Primers 5′-GATCGAATCC
ACCATGTCAGAGATGGTCAATGTG-3′ and 5′- GAT
CCTCGAGTTAAGCGTAATCTGGAACATCGTATGGG
TATTCAGTGAATATAGCATGGTGTG-3′ were used to
amplify the coding region of NeuroD4, adding a single
HA tag at the 3′ end before the stop codon, and intro-
ducing EcoR1 and Xho1 restriction enzyme sites to the ex-
treme 5′ and 3′ ends respectively. This PCR product was
digested with EcoR1 and Xho1 and ligated into a blank
pCS2+ vector. All phospho-mutant constructs, including
the HA-tagged 6T/S-A NeuroD4, were subsequently
generated from either the untagged WT NeuroD4 or
HA-tagged WT NeuroD4 constructs by site directed
mutagenesis. Single or multiple site mutation were per-
formed using the QuikChange II Site-Directed Mutagen-
esis Kit (Agilent Technologies) or the QuikChange Multi
Site-Directed Mutagenesis Kit (Agilent Technologies) re-
spectively, each according to manufacturer’s instructions
and using the PCR primers as shown in Table 1. All se-
quences were confirmed by Sanger sequencing of plasmid
DNA. Nucleotide and protein sequence alignments were
conducted using ClustalW software [50].
Xenopus laevis embryo manipulation
X. laevis eggs were obtained by standard hormone
methods of induction, and subsequently fertilised in vitro.
pCS2+ plasmids containing the various NeuroD4 con-
structs were linearised with Not1 enzyme and capped
mRNA was transcribed in vitro using the SP6 mMes-
sage mMachine® kit (Ambion). Unless otherwise stated,
two-cell-stage embryos were unilaterally injected into
the animal pole with 100 pg NeuroD4 mRNA in a total
volume of 10 nl, with co-injection of 500 pg GFP and
β-gal mRNA to enable lineage tracing. Embryos were
subsequently cultured at 16 °C in Ficoll solution (4 %Anti-sense primer 5′ to 3′
CTGGGTAGTCCTGGGGCCTGGTAATTATAAGTATG
GTTACCATAAGGAGGAGCGGGTAGTCCTGGGGCC
CTCCTTCATATGGTGGAGCGGTACAGTTAAGTGTATG
TGAGTGGAGGTGCTAGAGCTCCTTCATATGGTGGA
AAT ATTTATCCATATCGGGTGCACTATCTTGCTTCAAAGAAAAATTACC
AAGAGCTGGATAGGGGGCCCTGAATGCATATGATT
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and staged according to the methods of Niewkoop and
Faber [51]. At stage 18, embryos were either snap-
frozen for qRT-PCR analysis (see below), or fixed in
MEMFA (4 % formaldehyde, 100 mM MOPS, 2 mM
EGTA, 1 mM MgSO4, pH 7.5) for 90 min, washed twice
in phosphate-buffered saline (PBS), followed by PBS
supplemented with 2 mM MgCl2, and embryos were
stained with 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-
beta-D-galactopyranoside) in X-gal mixer (5.35 mM
K3Fe(CN)6, 5.35 mM K4Fe(CN)6, 1.2 mM MgCl2, 0.1 % so-
dium deoxycholate, 0.2 % NP-40 in PBS). Embryos were
again washed twice in PBS and dehydrated in methanol
prior to storage at −20 °C.Table 2 Primer sequences used in quantitative real-time PCR
Name Sequence (5′ to 3′) GenBank accession
number of gene
xEF1α F CACCATGAAGCCCTTACTGAG NM 001087442
xEF1α R TGATAACCTGTGCGGTAAATG
N-β-tubulin F TGGATTTGGAACCAGGCA NM 001086064
N-β-tubulin R GCTCAGCTCCTTCGGTGTA
p27Xic1 F ACTGAAGGAAATCCAAGCGTC NM 001114803
p27Xic1 R CTGGCTGTAGAAACTGGGCAT
xDelta F GCCCCAGAGATGATGCTTTC BC 070634
xDelta R GCCTTGCCAACCCACTCTACATTWhole mount in situ hybridisation
Dig-oxigenin-labelled anti-sense probes were synthesised
from the following plasmids: X. laevis neural-β-tubulin
[52]; X. laevis p27Xic1 [52]; X. laevis xMyt1 [27], X. laevis
xNeuroD1 (a kind gift from Professor Shin-Ichi Ohnuna
(University College London, UK); linearised with BamH1
and transcribed from T7) and X. laevis xHox11L2 [23].
Whole mount ISH was performed using a BioLane™ HTI
in situ robot (Holle and Huttner) with washes and com-
position of solutions as described in [53], with some modi-
fications. RNase treatment was omitted and blocking was
performed using 2 % Blocking Reagent (Roche) and 20 %
heat inactivated lamb serum in maleic acid buffer (0.1 M
maleic acid, 0.15 M NaCl, pH 7.5). This was then followed
by incubation in the same solution containing 1:5000 anti-
digoxigenin antibody-coupled to alkaline phosphatase
(Roche). The chromogenic reaction was conducted in BM
purple (Roche) and terminated by methanol washes prior
to overnight fixation in MEMFA. Embryos were then
washed in 0.1 % Tween-20 in PBS, and bleached on a light
box for 1 h in bleaching solution (10 % H2O2, 5 % form-
amide, 0.1 % SSC), prior to PBS washes and storage in
MEMFA at room temperature. Embryos were scored for
neurogenesis as described in Additional file 1 and repre-
sentative embryos from each category were photographed
using a CoolSNAP colour camera (RS Photometrics) and
Openlab™ software.xMyt1 F TAAAGTCGGGTCAAGCGGAA NM 001088192
xMyt1 R TTCATCTCTGGGTTCAGTGCC
xNeuroD1 F GACTCAACGATGCCCTGGA NM 001085794
xNeuroD1 R CCCGCTACTAGATTGGTGGTG
xHb9 F TCCGAGCACACTGACAGC NM 001096823
xHb9 R CATCGGGTGTCCATACAGG
xHox11L2 F CCCAGGACTTCATTCACCA NM 001085747
xHox11L2 R GGTTTTGACTTGGGCATCTG
xVsx1 F TTTGCCATCACTGACCTGCTT NM 001096722
xVsx1 R AAGCCACACAGAAAGCCCAGQuantitative real-time PCR (qRT-PCR)
Embryos for qRT-PCR analysis were co-injected with 500
pg mRNA encoding GFP, and GFP expression was
subsequently used to confirm successful injection. Sam-
ples of four embryos were snap-frozen at stage 18 and
whole embryo RNA was extracted using the Qiagen
RNeasy® Mini Kit. Template cDNAs were synthesised
using the QuantiTect® Reverse Transcription Kit (Qiagen),
and qRT-PCR was performed using the Quantifast® SYBR
Green PCR Kit (Qiagen) in a LightCycler® 480 (Roche).Thermal cycling conditions: 95 °C for 5 min, then 45 cy-
cles of 95 °C for 10 s, 60 °C for 10 s and 72 °C for 20 s. Pri-
mer sequences were as shown in Table 2.
Western blotting
For detection of NeuroD4 phosphorylation, embryos
were injected bilaterally at the two-cell stage with 300 pg
WT NeuroD4-HA mRNA. For comparison of WT and
6T/S-A NeuroD4 protein stability, embryos were injected
at the one cell stage with 200 pg of the respective HA-
tagged mRNA. Samples of five embryos were snap-frozen
on dry ice at stage 13 and subsequently lysed in 50ul of
pre-chilled IP-buffer (50 mM Tris pH7.9, 100 mM
NaCl, 5 mM EDTA, 0.1 % Triton-X-100, 50 mM β-
glycerophosphate, with 1:25 protease inhibitor cocktail
(Roche)). Lysed embryos were centrifuged at 4 °C for 5
min at 16 000 xg and the supernatant re-spun and final
supernatant used as the protein extract. Protein was quan-
tified in the extract using a BCA assay (Thermo Scientific)
according to manufacturer’s instructions, and 30ug was
subsequently used for Western blot analysis in a total vol-
ume of 10 ul. For detection of NeuroD4 phospho-status,
samples were incubated at 30 °C for 1 h in the presence or
absence of Lambda protein phosphatase (NEB). 3.5 ul of
SDS-loading buffer containing reducing agent was then
added to each sample and incubated at 70 °C for 10 min
prior to brief 15 s centrifugation. Samples were loaded on
to a pre-cast BioRad Criterion™ TGX™ 18 % gel using the
BioRad precision plus protein dual colour standard as a
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fer (25 mM Tris, 192 mM glycine, 0.1 % SDS, pH8.3).
Transfer was conducted at 100 mV for 45 min at 4 °C,
using pre-chilled transfer buffer (6 g Trizma Base, 28.8 g
Glycine, 400 ml Methanol in total 2 L volume) and PVDF
membrane activated in methanol. Blocking was performed
for over 1 h in 4 % milk in TBS with 0.1 % tween and the
membrane was cut at just below the 50KDa level to enable
separate antibody incubation to detect either the NeuroD4
protein or Tubulin loading control. Primary antibodies
were used at 1:2000 dilution in 2 % milk in TBS-T and
applied for at least 1 h at room temperature or 4 °C
overnight: rat HRP-conjugated anti-HA (clone 3 F10) anti-
body (Roche) and mouse anti-α-tubulin antibody (Sigma).
Membranes were washed at least 5 times in TBS-T and anti-
tubulin antibody was detected using an HRP-conjugated anti-
mouse antibody at 1:10000 dilution in 2 % milk in TBS-T for
1 h at room temperature. Membranes were washed again at
least 5 times prior to Amersham ECL detection reagent
reaction (GE Healthcare) according to manufacturer’s instruc-
tions. Experiments were conducted in independent duplicate
and representative images are shown. For protein quantifica-
tion in Fig. 7, ImageJ software was used to calculate the
density of the NeuroD4 protein band relative to the density
of the tubulin loading control band. An average value was
calculated for independent repeats and error margins were
calculated using the standard error of the mean.
Assay of chromatin association
Embryos were injected at the one cell stage with 200 pg
HA-tagged mRNA as before. At stage 14, embryos were
transfered to glass vials and rinsed 3 times with distilled
water. Embryos were then incubated at room temperature
for 30 min in 1 % formaldehyde in 0.1 % MBS solution,
prior to quenching in 0.25x MBS containing 125 mM gly-
cine for 30 min. Embryos were then washed twice for 30
min total in 0.25x MBS, and 30 embryos per condition were
snap-frozen on dry ice. Nuclei were extracted using a modi-
fied protocol for chromatin isolation. Embryos were homo-
genised in 50ul of Buffer E1 (50 mM Hepes-KOH pH7.5,
140 mM NaCl, 1 mM EDTA pH8.0, 10 % Glycerol, 0.5 %
NP-40, 0.25 % TritonX-100, 1 mM DTT, 0.2 mM PMSF
and protease inhibitor cocktail (Roche)) and spun for 2 min
at 3500 rpm at 4 °C. The supernatent was collected and
retained as the cytoplasmic fraction, and 10 ul of this was
subsequently used for Western Blot. The lipid residue was
removed and the remaining pellet was resuspended in 1 ml
of Buffer E1, followed by a repeat centrifugation step. The
pellet was again resuspended in 1 ml of Buffer E1, and sam-
ples were rested on ice for 10 min prior to centrifugation.
The resulting pellet was then resuspended in 50ul Buffer E2
(10 mM Tris pH8.0, 200 mM NaCl, 1 mM EDTA pH8.0,
0.5 mM EGTA pH 8.0, 0.2 mM PMSF and protease inhibi-
tor cocktail (Roche)), and the process was repeated with 2cycles of centrifugation and resuspension, followed by 10
min rest on ice before final centrifugation. The resulting pel-
let was resuspended in 250ul of Buffer E3 (500 mM Tris
pH8.0, 500 mM NaCl and protease inhibitor cocktain
(Roche)), and this represents the chromatin fraction.
20ul of the chromatin fraction was then DNAse treated
(Qiagen) at room temperature for 15 min and Western
Blot analysis was conducted as described above using
10ul samples. A 4-20 % gel was used and antibodies
were as above, with the additional use of Anti-Histone
H3 antibody (Abcam) and anti-rabbit secondary antibody
(Sigma). ImageJ software was again used to quantify
protein bands and the density of WT or 6T/S-A
NeuroD4 protein was calculated relative to tubulin pro-
tein or histone H3 protein for cytoplasmic and chroma-
tin fractions respectively.
Statistical analysis
For qRT-PCR data, mRNA expression was normalised to
expression of the housekeeping gene Elongation Factor 1α
(EF1α), and for analysis, mRNA levels in the injected em-
bryos were calculated relative to stage-matched uninjected
control embryos. Mean values and the standard error of
the mean (s.e.m.) were calculated from at least three inde-
pendent experiments (n = 3). Statistical significance was
determined using a paired two-tailed Student’s t-test with
(p < 0.05) = *; (p < 0.025) = **; (p < 0.0125) = ***. For in situ
hybridisation data, embryos were scored for the extent
and pattern of marker gene expression on the injected side
of the embryo relative to the uninjected side and unin-
jected control embryos. Additional file 1 provides repre-
sentative images and descriptions for the scoring of
neural-β-tubulin expression, and similar principles were
applied to scoring the expression of p27Xic1, xMyt1 and
xNeuroD1. Experiments were conducted in independent
duplicate or triplicate and the n numbers reported refer to
the range of total numbers of embryos in each injection
category. Statistical significance was determined between
categories using a Fisher’s Exact Test for Count Data, and
p values are illustrated as described above.Additional file
Additional file 1: Representative embryo images to demonstrate
semi-quantitative scoring system used for in situ hybridisation data.
Neurogenesis was graded by comparing the extent and pattern of neural
β-tubulin expression following in situ hybridisation on the injected side of
the embryo relative to the uninjected side and uninjected control embryos.
Scores were assigned as: 0, no difference; +1, mild increase in neurogenesis
within the neural plate, with or without occasional ectopic neurons on
the injected side; +2, moderate increase in neurogenesis with ectopic
expression of neural β-tubulin occurring in patches on the injected side and
sometimes bilaterally; +3, marked increase in neurogenesis with extensive
ectopic expression of neural β-tubulin in a more homogenous pattern on
the injected side and sometimes bilaterally.
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